Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Achillion Pharmaceuticals, Inc. (NQ: ACHN)
7.640 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Achillion Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 Next >
Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C
April 21, 2012
Posters Detailing ACH-1625, ACH-3102 and ACH-2928 Presented at the International Liver Congress(TM) 2012 Read More
from GlobeNewswire News Releases
Achillion Reports 2011 Fourth Quarter and Year-End Financial Results
March 08, 2012
Conference Call and Webcast to be Held Today, March 8th, at 8:30am ET Read More
from GlobeNewswire News Releases
Achillion Fourth Quarter and Full Year 2011 Financial Release and Conference Call Alert
March 02, 2012
Conference Call and Live Webcast Will be Hosted at 8:30 a.m. on March 8, 2012 Read More
from GlobeNewswire News Releases
Achillion to Present at Two Upcoming Investor Conferences
March 01, 2012
from GlobeNewswire News Releases
AMRS, KWK, ACHN, DNDN, and JAZZ Could See Big Gains, Reports Thestockfather.com
February 25, 2012
from EmailWire.Com Press Releases
2012 Economic Outlook - Report Highlights Achillion Pharmaceuticals, Inc. and Fusion-IO, Inc.
February 22, 2012
from Marketwired News Releases
Virology Profile Following Treatment With ACH-1625 Discussed in Oral Presentation at 2012 Asian Pacific Liver Conference
February 16, 2012
from GlobeNewswire News Releases
Achillion to Present at Three Upcoming Investor Conferences
February 08, 2012
from GlobeNewswire News Releases
Emerald Holds Annual Groundhog Day Investment Forum
February 06, 2012
from Business Wire News Releases
Achillion Announces Executive Promotion
February 03, 2012
from GlobeNewswire News Releases
Top Stock Alerts for Day Traders: Atmel, R.R. Donnelley & Sons, BioLineRx, Achillion Pharmaceuticals, Windstream and Rare Element Resources
January 25, 2012
from PR Newswire
Achillion to Present at the Noble Financial Capital Markets' Eighth Annual Equity Conference
January 13, 2012
from GlobeNewswire News Releases
A Forward Look, the Year Ahead -- Featured Research on Achillion Pharmaceuticals, Inc. and Nektar Therapeutics
January 13, 2012
from Marketwired News Releases
Research Reports on Top Traded Stocks: Zynga, JetBlue Airways, Flextronics, Achillion Pharmaceuticals, Hercules Offshore and Minefinders
January 10, 2012
from PR Newswire
Achillion Reports Clinical Data on Portfolio of Protease Inhibitors
January 09, 2012
from GlobeNewswire News Releases
ACH-1625 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C
January 04, 2012
from GlobeNewswire News Releases
Achillion Announces Preliminary Phase 1b Proof-of-Concept Data With ACH-2928 NS5A Inhibitor for the Treatment of Hepatitis C
December 05, 2011
Achieves 3.68 Log10 Reduction in HCV RNA After Three Days of Treatment Read More
from GlobeNewswire News Releases
Achillion to Present at the 23rd Annual Piper Jaffray Health Care Conference
November 21, 2011
from GlobeNewswire News Releases
Achillion Reports Third Quarter and Nine Month 2011 Financial Results
November 08, 2011
from GlobeNewswire News Releases
A Turn in Tide, Europe's New Deal - Research Report on Achillion Pharmaceuticals, Inc. and Idenix Pharmaceuticals, Inc.
November 07, 2011
from Marketwired News Releases
Achillion to Present at the Credit Suisse 2011 Healthcare Conference
November 03, 2011
from GlobeNewswire News Releases
Achillion Announces Nomination of Second Generation NS5A Inhibitor for the Treatment of Hepatitis C
October 13, 2011
from GlobeNewswire News Releases
Achillion to Present Updated Clinical and Preclinical Data on Multiple Compounds at AASLD 2011
October 03, 2011
from GlobeNewswire News Releases
Achillion to Present at the JMP Healthcare Conference
September 22, 2011
from GlobeNewswire News Releases
Global Situation & Resulting Influences - Research Report on Achillion Pharmaceuticals, Inc. and Nektar Therapeutics
September 20, 2011
from Marketwired News Releases
Achillion to Present at Two Upcoming Investor Conferences
August 31, 2011
from GlobeNewswire News Releases
Mega Stock Picks Initiates Coverage on GenVec Inc. (GNVC)
August 31, 2011
from EmailWire.Com Press Releases
Achillion Reports Second Quarter and Six Month 2011 Financial Results
August 08, 2011
from GlobeNewswire News Releases
Achillion to Host Conference Call to Discuss Second Quarter Financial Results and Upcoming Milestones
August 02, 2011
Conference Call Scheduled for 10:30 a.m. EDT on Tuesday, August 9, 2011 Read More
from GlobeNewswire News Releases
Achillion Announces Executive Promotion
July 26, 2011
from GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here